Holen Sie sich die Stockscreener-App
233.63
1.19%
-2.81
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HUM?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$236.44
Offen:
$237.755
24-Stunden-Volumen:
1.49M
Relative Volume:
0.71
Marktkapitalisierung:
$28.05B
Einnahmen:
$137.20B
Nettoeinkommen (Verlust:
$1.15B
KGV:
25.00
EPS:
9.3439
Netto-Cashflow:
$1.27B
1W Leistung:
+8.55%
1M Leistung:
+32.03%
6M Leistung:
-16.02%
1J Leistung:
-8.75%
1-Tages-Spanne:
$231.12
$238.13
1-Wochen-Bereich:
$213.90
$246.82
52-Wochen-Spanne:
$163.11
$315.35
Humana Inc Stock (HUM) Company Profile
Firmenname
Humana Inc
Sektor
Branche
Telefon
(502) 580-1000
Adresse
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, ELV, CI
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
233.63 | 28.05B | 137.20B | 1.15B | 1.27B | 9.3439 |
UNH
Unitedhealth Group Inc
|
368.78 | 334.93B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
82.09 | 105.21B | 402.11B | 1.73B | 7.81B | 1.3835 |
ELV
Elevance Health Inc
|
372.68 | 80.93B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
282.90 | 74.83B | 223.86B | 6.53B | 8.39B | 23.60 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-02-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2026-01-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-12-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-09-22 | Eingeleitet | Evercore ISI | In-line |
| 2025-05-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-10-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-02 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-03-22 | Eingeleitet | Raymond James | Mkt Perform |
| 2024-03-13 | Herabstufung | Argus | Buy → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-12 | Hochstufung | Argus | Hold → Buy |
| 2023-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-07-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-06-23 | Herabstufung | Argus | Buy → Hold |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-04-13 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-11-04 | Bestätigt | Barclays | Overweight |
| 2021-11-04 | Bestätigt | Credit Suisse | Outperform |
| 2021-11-04 | Bestätigt | Morgan Stanley | Overweight |
| 2021-11-04 | Bestätigt | Oppenheimer | Outperform |
| 2021-11-04 | Bestätigt | RBC Capital Mkts | Outperform |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-09-09 | Fortgesetzt | Barclays | Overweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Neutral |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-01-04 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-16 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-01-03 | Bestätigt | JP Morgan | Overweight |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-12-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-08 | Bestätigt | BofA/Merrill | Buy |
| 2018-09-13 | Eingeleitet | Barclays | Overweight |
| 2018-07-12 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-07-06 | Bestätigt | Piper Jaffray | Overweight |
| 2018-06-01 | Fortgesetzt | Citigroup | Buy |
| 2018-02-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | Bestätigt | Leerink Partners | Outperform |
| 2018-01-12 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Humana Inc Aktie (HUM) Neueste Nachrichten
Humana Inc. stock underperforms Friday when compared to competitors - MarketWatch
Humana (NYSE:HUM) Given New $214.00 Price Target at JPMorgan Chase & Co. - MarketBeat
TD Cowen Adjusts Price Target on Humana to $211 From $173 - marketscreener.com
Raymond James Adjusts Price Target on Humana to $260 From $230 - marketscreener.com
JPMorgan Adjusts Price Target on Humana to $214 From $180 - marketscreener.com
Humana (NYSE:HUM) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says - MarketBeat
Mizuho Forecasts Strong Price Appreciation for Humana (NYSE:HUM) Stock - MarketBeat
Humana (NYSE:HUM) Price Target Raised to $195.00 at The Goldman Sachs Group - MarketBeat
Humana (NYSE:HUM) Price Target Raised to $250.00 - MarketBeat
Humana (NYSE:HUM) Stock Price Expected to Rise, Leerink Partners Analyst Says - MarketBeat
Humana Investor Suit Largely Survives Dismissal Bid - Law360
FRANKLIN RISING DIVIDENDS VIP FUND's Humana Inc(HUM) Holding History - GuruFocus
Humana Pulls Back The Curtain On Planning For 2027 MA Bids - Word & Brown General Agency
Goldman Sachs Adjusts Humana's PT to $195 From $158, Keeps Sell Rating - marketscreener.com
Oppenheimer Adjusts Price Target on Humana to $260 From $250, Maintains Outperform Rating - marketscreener.com
UBS Adjusts Humana Price Target to $262 From $195, Maintains Neutral Rating - marketscreener.com
Humana Q1 2026: Revenue Jumps 23%, But Margin Compression Tells the Real Story - TIKR.com
Jefferies Adjusts Price Target on Humana to $290 From $235 - marketscreener.com
Barclays Adjusts Price Target on Humana to $180 From $176 - marketscreener.com
Guggenheim Adjusts Price Target on Humana to $269 From $252 - marketscreener.com
RBC Raises Price Target on Humana to $246 From $189, Keeps Sector Perform Rating - marketscreener.com
Vanguard reports 9.07M Humana holdings (NYSE: HUM) with 7.55% stake - Stock Titan
Deutsche Bank Aktiengesellschaft Increases Humana (NYSE:HUM) Price Target to $235.00 - MarketBeat
Humana (NYSE:HUM) Price Target Raised to $270.00 at Truist Financial - MarketBeat
Deutsche Bank Adjusts Humana Price Target to $235 From $180, Maintains Hold Rating - marketscreener.com
Humana Inc. (NYSE:HUM) Q1 2026 Earnings Call Transcript - Insider Monkey
Guggenheim raises Humana stock price target to $269 on earnings beat - Investing.com
UBS raises Humana stock price target to $262 on margin outlook - Investing.com
Growth at Humana providing ‘tailwind’ for CenterWell Home Health, exec says - McKnights Home Care
BofA raises Humana stock price target on maintained guidance - Investing.com
Humana Q1 Earnings Call Highlights - MarketBeat
RBC Capital raises Humana stock price target on cost trend outlook - Investing.com
Humana Inc (HUM) Q1 2026 Earnings Call Highlights: Strategic Gro - GuruFocus
Humana (NYSE:HUM) Posts Earnings Results, Beats Expectations By $0.31 EPS - MarketBeat
Evercore ISI raises Humana stock price target on earnings beat - Investing.com
Evercore ISI raises Humana stock price target on earnings beat By Investing.com - Investing.com Canada
Mizuho raises Humana stock price target to $290 on MLR beat - Investing.com
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Humana stock jumps 5% following quarterly results - Yahoo Finance
Humana beats Q1 but flat forecast sends shares falling 5% - Rolling Out
Tranche Update on Humana Inc.'s Equity Buyback Plan announced on February 15, 2024. - marketscreener.com
[10-Q] HUMANA INC Quarterly Earnings Report - Stock Titan
Humana (NYSE:HUM) Shares Gap DownTime to Sell? - MarketBeat
Humana Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Humana Beats Q1 Earnings Estimates on Increasing Premiums - Yahoo Finance
Humana Earnings Beat Estimates. The Stock Is Gaining. - Barron's
Humana shifts stance on Medicare Advantage benefit cuts - Modern Healthcare
Humana (HUM) Q1 2026 Earnings Call Transcript - AOL.com
What's Going On With Humana Stock Wednesday?Humana (NYSE:HUM) - Benzinga
Profit recovery is ‘priority No. 1,’ Humana promises - Healthcare Dive
Humana teams with Mark Cuban's Cost-Plus Drug Company - Healthcare Finance News
Finanzdaten der Humana Inc-Aktie (HUM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Humana Inc-Aktie (HUM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ventura Joseph C | Chief Legal Officer |
Feb 24 '26 |
Option Exercise |
0.00 |
1,035 |
0 |
17,565 |
| Renaudin George II | President, Insurance |
Feb 24 '26 |
Option Exercise |
0.00 |
1,035 |
0 |
16,494 |
| Felter John-Paul W. | SVP, Chief Accting Off & Cont. |
Feb 24 '26 |
Option Exercise |
0.00 |
165 |
0 |
7,568 |
| Shetty Sanjay K | President, CenterWell |
Feb 23 '26 |
Buy |
185.21 |
810 |
150,016 |
11,657 |
| Dintenfass David | President, Enterprise Growth |
Feb 21 '26 |
Option Exercise |
0.00 |
3,858 |
0 |
15,316 |
| Mehta Japan | Chief Information Officer |
Feb 13 '26 |
Option Exercise |
0.00 |
1,682 |
0 |
8,158 |
| Mellet Celeste | Chief Financial Officer |
Feb 13 '26 |
Option Exercise |
0.00 |
7,763 |
0 |
28,454 |
| Rechtin James A. | President & CEO |
Jan 08 '26 |
Option Exercise |
0.00 |
2,183 |
0 |
29,285 |
| O'Hara Michelle A. | Chief Human Resources Officer |
Jan 01 '26 |
Option Exercise |
0.00 |
2,353 |
0 |
10,634 |
| Mellet Celeste | Chief Financial Officer |
Dec 15 '25 |
Option Exercise |
0.00 |
2,128 |
0 |
29,676 |
0.65%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):